Hypoglycemic neuropathy

Acta Neuropathologica

Volumn 102, Issue 5, 2001, Pages 413-421

  Mohseni, S ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Central nervous system; Hypoglycemic neuropathy; Insulin treatment; Insulinoma; Peripheral nervous system

Indexed keywords

ANTIDIABETIC AGENT; ASPARTIC ACID; EXCITOTOXIN; INSULIN; MYELIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOPSY; BRAIN CORTEX; BRAIN STEM; CELL LOSS; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CLINICAL OBSERVATION; CLINICAL RESEARCH; CLINICAL STUDY; COGNITIVE DEFECT; CONCENTRATION LOSS; CONTROLLED STUDY; CONVULSION; DEGENERATION; DIABETES MELLITUS; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; EXPERIENCE; EXPOSURE; GLIA CELL; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; HYPOGLYCEMIC COMA; INSULINOMA; IRRITABILITY; MOTONEURON; NERVE CELL; NERVE FIBER; NEUROPATHY; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; REGENERATION; REVIEW; SENSORY NERVE CELL; SPINAL CORD; SYMPTOM; UNCONSCIOUSNESS;

EID: 0034773762     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010100459     Document Type: Review

References (150)

1. Local cerebral blood flow in the rat during severe hypoglycemia, and in the recovery period following glucose injection
2. Cerebral metabolic changes in profound, insulin-induced hypoglycemia, and in the recovery period following glucose administration
3. Hypoglycemic brain injury. I. Metabolic and light microscopic findings in rat cerebral cortex during profound insulin-induced hypoglycemia and the recovery period following glucose administration
4. Hypoglycemic brain injury: Metabolic and structural findings in rat cerebellar cortex during profound insulin-induced hypoglycemia and in the recovery period following glucose administration
5. Influence of severe hypoglycemia on mitochondrial and plasma membrane function in rat brain
6. Pathophysiology of ischemic cell death. I. Time of onset of irreversible damage; importance of the different components of ischemic insult
7. Pathophysiology of ischemic cell death. II. Changes in plasma membrane permeability and cell volume
8. Protection against CNS ischemia by temporary interruption of function-related processes of neurons
9. Neurotrophic factors and diabetic peripheral neuropathy
10. Newborn hypoglycemia
11. Progress review: Hypoglycemic brain damage
12. Assessing structural changes in the brain to evaluate neurotoxicological effects of NMDA receptor antagonists
13. Hypoglycemic brain damage: Effect of a dihydropyridine calcium channel antagonist in rats
14. Biological differences between ischemia, hypoglycemia, and epilepsy
15. Hypoglycemia: Brain neurochemistry and neuropathology
16. Hypoglycemic brain injury in the rat. Correlation of density of brain damage with the EEG isoelectric time: A quantitative study
17. The distribution of hypoglycemic brain damage
18. The temporal evolution of hypoglycemic brain damage. I. Light- and electron-microscopic findings in the rat cerebral cortex
19. The temporal evolution of hypoglycemic brain damage. II. Light- and electron-microscopic findings in the hippocampal gyrus and subiculum of the rat
20. Hypotension as a complication of hypoglycemia leads to enhanced energy failure but no increase in neuronal necrosis
21. Neuropathologic findings in three cases of profound hypoglycemia
22. Cerebral lesions in hypoglycemia. II. Some possibilities of irrevocable damage from insulin shock
23. Cerebral damage in hypoglycemia. A review
24. Cerebral lesions in
25. Hypoglycemia and glucose sensing
26. Peripheral sensory-motor polyneuropathy, pigmentary retinopathy, and fatal cardiomyopathy in long-chain 3-hydroxyl-acyl-CoA dehydrogenase deficiency
27. Severe hypoglycemia caused by raised insulin-like growth factor II in disseminated breast cancer
28. Diabetic neuropathy: Pathogenesis and current treatment perspectives
29. Hypoglycemic thresholds for cognitive dysfunction in humans
30. Hypoglycemia unawareness
31. How to ameliorate the problem of hypoglycemia in intensive as well as nonintensive treatment of type 1 diabetes
32. The nature and time course of the neuronal alterations resulting from oligaemia and hypoglycemia in the brain of Macaca mulatta
33. Hypoglycemia associated with a solitary fibrous tumour of the pleura
34. Hypoglycemia in children with type 1 diabetes
35. Late cerebral changes incident to severe hypoglycemia (insulin shock)
36. Hypoglycemia
37. Pathophysiology and treatment of diabetic neuropathy
38. Pathologic alterations in diabetic neuropathies of human: A review
39. Peripheral neuropathy associated with functional islet cell adenomas in SV40 transgenic mice
40. Sustained elevation of cerebral blood flow after hypoglycemia in normal man
41. Hypoglycemia and the nervous system
42. Hypoglycemia on and after admission in Kenyan children with severe malaria
43. Mitochondrial permeability transition induced DNA-fragmentation in the rat hippocampus following hypoglycemia
44. Histologic evidence of damage to the brain in monkeys treated with Metrazol and insulin
45. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death
46. Hyperinsulinism of the newborn
47. Adenosine reduces cortical neuronal injury induced by oxygen or glucose deprivation in vitro
48. Changes in the central nervous system resulting from convulsion due to hyperinsulinism
49. Diabetic neuropathy: Scope of the syndrome
50. Does holiday hypoglycemia exist?
51. The mitochondrial permeability transition: Its molecular mechanism and role in reperfusion injury
52. Cerebral extracellular calcium activity in severe hypoglycemia: Relation to extracellular potassium and energy state
53. Muscle wasting after prolonged hypoglycemic coma: Case report with electrophysiological data
54. Causes, management and morbidity of acute hypoglycemia in adults requiring hospital admission
55. Hypogycemia in patients with renal failure
56. Hypoglycemia and the neonatal brain
57. Diabetic hypoglycemia
58. Variable deterioration in cortical function during insulin-induced hypoglycemia
59. Verbal fluency and naming performance in type I diabetes at different blood glucose concentrations
60. The exacerbating effect of insulin-induced hypoglycemia on spontaneous peripheral neuropathy in aged B6C3F1 mice
61. Diagnosis and management of diabetic peripheral neuropathy
62. Biological and behavioural determinants of the frequency of mild, biochemical hypoglycemia in patients with type 1 diabetes on multiple insulin injection therapy
63. Hypoglycemic peripheral neuropathy in association with insulinoma: Implication of glucopenia rather than hyperinsulinism
64. A case of insulinoma with peripheral neuropathy
65. Muscle damage induced by experimental hypoglycemia
66. Hypoglycemic brain damage in the neonatal rat
67. Neurological manifestation of hypoglycemia
68. Effects of severe hypoglycemia on the human brain. Neuropathological case reports
69. Hypoglycemic brain injury. II. Electron-microscopic findings in rat cerebral cortical neurons during profound insulin-induced hypoglycemia and in the recovery period following glucose administration
70. The temporal evolution of hypoglycemic brain damage. III. Light and electron microscopic findings in the rat caudoputamen
71. Cerebral protein synthesis during long-term recovery from severe hypoglycemia
72. Anti-insulin antibodies may cause hypoglycemia following pancreas transplantation
73. The pathological changes in the brain in fetal hypoglycemia
74. Changes in carbohydrate substrates, amino acids and ammonia in the brain during insulin-induced hypoglycemia
75. Cerebral energy state in insulin-induced hypoglycemia, related to blood glucose and to EEG
76. Selective lesions of mesostriatal dopamine neurons ameliorate hypoglycemic damage in the caudate-putamen
77. Hypoglycemia during intensified insulin therapy of children and adolescents
78. Hyperinsulinism and cerebral changes
79. The pathology of human diabetic neuropathy
80. Cognitive function and mood after profound nocturnal hypoglycemia in prepubertal children with conventional insulin treatment for diabetes
81. Avoiding stroke during cerebral arterial occlusion by temporarily blocking neuronal functions in the rabbit
82. Magnesium plus mexiletine inhibit energy usage and protect retinas against ischemia
83. Hypoglycemia, the most feared complication of insulin therapy
84. Anger state during acute insulin-induced hypoglycemia
85. Hypoglycemia unawareness
86. Hypoglycemia. Neurologic and neuropathologic
87. Hypoglycemic neuropathy in diabetic BB/Wor rats treated with insulin implants affects ventral root axons but not dorsal root axons
88. Neuropathy in diabetic BB/Wor rats treated with insulin implants
89. Neuropathy in diabetic BB/Wor rats treated with insulin implants. Electron microscopic observations
90. Hypoglycemic neuropathy: Occurrence of axon terminals in plantar skin and plantar muscle of diabetic BB/Wor rats treated with insulin implants
91. Glucose deprivation neuronal injury in cortical culture
92. Hyperinsulin neuronopathy
93. Cranial MRI of neurologically impaired children suffering from neonatal hypoglycemia
94. Insulin-induced hypoglycemia in the non-human primate. II. Long-term neurological consequence
95. Long-term follow up of insulin-dependent diabetes mellitus patients with recurrent episodes of severe hypoglycemia
96. Hypoglycemia in association with various organic and amino acid disorders
97. Regional neuroprotective effects of the NMDA receptor antagonist MK-801 (dizocilpine) in hypoglycemic brain damage
98. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus
99. Regulation of extra- and intracellular pH in the brain in severe hypoglycemia
100. Hypoglycemic neuropathy in experimental diabetes
101. Effects of spontaneous chronic hypoglycemia on central and peripheral nervous system in insulinoma patients before and after surgery: A neurophysiological follow-up
102. Cognitive function during hypoglycemia in type I diabetes mellitus
103. The neuropathy of hypoglycemia
104. Excitotoxicity and the NMDA receptor
105. Diabetic neuropathy: An update
106. Incidence of distal symmetric (sensory) neuropathy in NIDDM. The San Luis Valley diabetes study
107. Pharmacological and functional characterization of excitatory amino acid mediated cytotoxicity in cerebral cortical neurons
108. Nervous and mental phenomena accompanying insulin therapy
109. Hypoglycemic brain lesions in a dog with insulinoma
110. Peripheral neuropathy in rats induced by insulin treatment
111. Anterograde fast component of axonal transport during insulin-induced hypoglycemia in non-diabetic and diabetic rats
112. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: A unifying hypothesis
113. Polyneuritis hypoglycemica. Late peripheral paresis after hypoglycemic attacks in two insulinoma patients
114. Neuropathology of diabetic neuropathy and its correlations with neurophysiology
115. Diabetic neuropathies
116. Diabetic and hypoglycemic neuropathy - A comparison in the BB rat
117. Hyperinsulinemic hypoglycemia of infancy. Recent insights into ATP-sensitive potassium channels, sulfonylurea receptors, molecular mechanisms, and treatment
118. Higher incidence of severe hypoglycemia leading to hospital admission in type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas
119. Occurrence of epidermal nerve endings in glabrous and hairy skin of the foot after sciatic nerve regeneration
120. Molecular basis of glutamate toxicity in retina ganglion cells
121. Peripheral nerve pathology in rats with streptozotocin-induced insulinoma
122. Diabetic neuropathy - A continuing enigma
123. Neurophysiological changes during insulin-induced hypoglycemia and in the recovery period following glucose infusion in type 1 (insulin-dependent) diabetes mellitus and in normal man
124. Changes in central and peripheral nervous system function during hypoglycemia in man: An electro-physiological quantification
125. Electroencephalography and visually evoked potentials during moderate hypoglycemia
126. Fibrolamellar hepatocellular carcinoma in a Thai man who presented with hypoglycemia: Case report and review of literature
127. Changes in the brain in a case of fatal insulin shock
128. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
129. Hypoglycemia in the diabetes control and complications trial
130. Diabetic peripheral neuropathies: Their cost to patient and society and the value of knowledge of risk factors for development of interventions
131. Peripheral neuropathy in association with insulinoma: Clinical features and neuropathology of a new case
132. Presumed apoptosis and reduced arcuate nucleus neuropeptide Y and pro-opiomelanocortin mRNA in non-coma hypoglycemia
133. Hypoglycemia from islet cell tumor of pancreas with amyotrophy and cerebrospinal nerve cell changes
134. Brain imaging in neonatal hypoglycemia
135. Severe hypoglycemia in children and adolescents during multiple-dose insulin therapy
136. Treatment of a dog with an insulinoma-related peripheral polyneuropathy with corticosteroids
137. Diabetic neuropathy: Pathogenesis and therapy
138. Insulin autoimmune syndrome: A rare cause of hypoglycemia not to be overlooked
139. Hypoglycemia
140. Histopathologic changes in the brain in experimental hyperinsulinism
141. Changes in excitatory amino acid receptor binding in the intact and decorticated rat neostriatum following insulin-induced hypoglycemia
142. Degenerative neuropathy in insulin-treated diabetic rats
143. Influence of severe hypoglycemia on brain extracellular calcium and potassium activities, energy, and phospholipid metabolism
144. Lesions of the glutamatergic cortico-striatal projections in the rat ameliorate hypoglycemic brain damage in the striatum
145. Amyotrophy due to hypoglycemia
146. Neurohistopathologic changes with metrazol and insulin shock terapy. An experimental study on the cat
147. Permanent neuropsychological impairment after recurrent episodes of severe hypoglycemia in man
148. Pathogenetic mechanisms of diabetic neuropathy: Lessons from animal models
149. Duration and severity of hypoglycemia needed to induce neuropathy
150. Spatial distribution of fibre degeneration in acute hypoglycemic neuropathy in rat